Home › Trial NCT06949124
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
- Trial IDNCT06949124
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorJiangsu HengRui Medicine Co., Ltd.
- Enrollment20
- Start date2025-04-28
- ConditionsEndometriosis · Uterine Fibroids · Assisted Reproduction
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.